From the daily archives: Thursday, January 7, 2010

Secretary Napolitano Outlines Five Recommendations To Enhance Aviation Security

Release Date: January 7, 2010

For Immediate Release
Office of the Press Secretary
Contact: 202-282-8010

Department of Homeland Security (DHS) Secretary Janet Napolitano today joined White House Press Secretary Robert Gibbs and Assistant to the President for Counterterrorism and Homeland Security John Brennan to announce several recommendations DHS has made to the President for improving the technology and procedures used to protect air travel from acts of terrorism. Secretary Napolitano outlined five recommendations DHS will pursue to enhance the safety of the traveling public—developed as a result of the security reviews ordered by President Obama following the attempted terrorist attack on Dec. 25, 2009.

“The attempted attack on Christmas Day is a powerful illustration that terrorists will go to great lengths to try to defeat the security measures that have been put in place since Sept. 11, 2001,” said Secretary Napolitano. “These recommendations will strengthen aviation security—at home and abroad—through new partnerships, technology and law enforcement efforts.”

Secretary Napolitano outlined the following five recommendations:

  • Re-evaluate and modify the criteria and process used to create terrorist watch lists—including adjusting the process by which names are added to the “No-Fly” and “Selectee” lists.
  • Establish a partnership on aviation security between DHS and the Department of Energy and its National Laboratories in order to develop new and more effective technologies to deter and disrupt known threats and proactively anticipate and protect against new ways by which terrorists could seek to board an aircraft.
  • Accelerate deployment of advanced imaging technology to provide greater explosives detection capabilities—and encourage foreign aviation security authorities to do the same—in order to identify materials such as those used in the attempted Dec. 25 attack. The Transportation Security Administration currently has 40 machines deployed throughout the United States, and plans to deploy at least 300 additional units in 2010.
  • Strengthen the presence and capacity of aviation law enforcement—by deploying law enforcement officers from across DHS to serve as Federal Air Marshals to increase security aboard U.S.-bound flights.
  • Work with international partners to strengthen international security measures and standards for aviation security.

Secretary Napolitano will travel to Spain later this month to meet with her international counterparts in the first of a series of global meetings intended to bring about broad consensus on new international aviation security standards and procedures.

Deputy Secretary Jane Holl Lute, Assistant Secretary for Policy David Heyman and other senior Department officials already have embarked on a broad international outreach effort to meet with leaders from major international airports in Africa, Asia, Europe, the Middle East and South America to review security procedures and technology being used to screen passengers on U.S.-bound flights and work on ways to collectively bolster tactics for defeating terrorists.

Secretary Napolitano’s recommendations come in addition to the Department’s immediate actions following the attempted attack on Dec. 25, 2009—including enhanced security measures at domestic airports and new international security directives that mandate enhanced screening of every individual flying into the United States from or through nations that are State Sponsors of Terrorism or other countries of interest and the majority of all passengers traveling on U.S.-bound flights.

 

 

TamaleFest04

 

A fifth suspicious envelope was discovered — but not opened — Wednesday, Jan. 6, by a UC Irvine staffer working in the Arts, Culture & Technology building. The letter was addressed to a male associate professor of the arts. A woman opening the mail detected a granular substance in the envelope and called UCI police.  The powder will be tested. Powder from four identical envelopes — two discovered Monday and two more opened Tuesday — has been analyzed and was found to be harmless. No one has become ill.

The letters are believed to have been received by the campus during the December closure. Distribution and Document Management is now screening incoming mail for suspicious envelopes similar to those described above; however, mail that came in over the holidays was not screened using these criteria and much of it has already been distributed to campus departments. Therefore, caution is recommended when examining incoming mail. If you receive an envelope with an Idaho postmark from someone you do not know, do not open it; immediately call 911 or the UC Irvine Police Department at 949-824-5223.

With the Wednesday, Jan. 6, mail delivery, DDM provided plastic bags and instructions for handling items that you feel are suspicious but do not meet the criteria described above. You may return the unopened, suspicious item to DDM in the plastic bag. UCI Police will be present when suspicious items are opened for inspection. If the contents do not include a threatening message, or indicate the potential for a biological or chemical hazard, the item will be resealed with a label indicating it has been opened for inspection, and will then be delivered to the designated department.

We anticipate that the new screening procedure will delay delivery by no more than 24 hours. Full procedures for handling suspicious mail can be viewed at www.ddm.uci.edu.

These incidents are a serious crime and are being investigated in cooperation with federal authorities. Individuals responsible will be prosecuted to the full extent of the law.

 

There Is a New Pre-Symptomatic Screening Test for Ovarian Cancer Coming
From Arrayit Corporation, and It Will Be Available Soon

Noninvasive Test Will Provide Hope for 90% of Women Diagnosed With This Silent Killer

SUNNYVALE, CA–(Marketwire – 01/07/10) – On December 9th, 2009, Arrayit Corporation (OTCBB: ARYC) , a leading manufacturer of products and services for disease prevention, treatment and cure,
announced a breakthrough in ovarian cancer screening utilizing a microarray-based diagnostic
test that will detect whether a patient is pre-symptomatic for this silent killer.

In a report by NBC`s Dr. Robert Bezell on Tuesday, January 5th, it was reported that although
research continues, there is no effective screening test currently available to detect the
pre-symptomatic presence of ovarian cancer. The report missed the mark, which indicates that press
information distributed by Arrayit on December 9th, somehow fell through the cracks. The fact
is, Arrayit`s advanced screening test, OvaDx(TM), will be available very soon.

Researchers at a major cancer research institute have worked for six years to identify more than 100 biomarkers
unique to ovarian cancer. The proteomic markers were finally identified using a novel and
patented microarray platform created by Arrayit. A noninvasive screening test can be
performed via a simple blood test that can be conducted during annual physical exams. The test will
soon be submitted to the FDA for approval, and since it is an in vitro diagnostic
multivariate index assay, prompt approval is anticipated.

According to the American Cancer Society, more than 21,500 women will be diagnosed with Ovarian Cancer this year, and
14,000 will die. Up until now, screening tests could only detect the `Silent Killer` when the
disease is symptomatic, meaning the disease has progressed to stage 3 or 4. Unfortunately at
this late stage of detection the cancer most certainly has metastasized and spread beyond the ovary,
which proves fatal for 75% of women diagnosed.

Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of the
female reproductive system. Clinicians state that the primary reasons for such a high
fatality rate are that there are no discernable early symptoms, and there has not been an effective
early detection test available. The American Cancer Society estimates that 90% of woman diagnosed
with ovarian cancer could survive with early detection. Currently only 20% of women diagnosed are
in the early stages.

The early detection of ovarian cancer holds tremendous potential to profoundly impact the quality of life of
ovarian cancer victims and shift costs from treatment to detection ensuring survivability for a
larger population. Upon FDA approval, OvaDx(TM) will be marketed and sold by Arrayit
Corporation`s subsidiary, Arrayit Diagnostics (Ovarian), Inc., in Houston, Texas under a licensing agreement.

 
%d bloggers like this: